Related Experiment Video

Updated: Aug 9, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

[Viral hepatitides infections in transplant recipients]

Lluís Castells1

  • 1Servicio de Medicina Interna-Hepatología, Hospital General Universitario Vall d'Hebron, Universidad Autónoma, Barcelona, España. llcastells@vhebron.net

Enfermedades Infecciosas Y Microbiologia Clinica
|March 21, 2006
PubMed

Insights

Hepatitis C (HCV) recurrence post-liver transplant (LTx) significantly impacts survival due to limited treatment options. Hepatitis B virus (HBV) recurrence is manageable with careful patient selection and antiviral therapies, improving outcomes.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Virology

Context:

  • Hepatitis C virus (HCV) and hepatitis B virus (HBV) are leading causes of end-stage liver disease necessitating liver transplantation (LTx).
  • Recurrent HCV infection post-LTx is universal, often progressing faster than in non-immunosuppressed individuals, jeopardizing graft and patient survival.
  • HBV recurrence risk is linked to viral replication status at the time of LTx.

Purpose:

  • To review the challenges and outcomes of managing HCV and HBV recurrence after liver transplantation.
  • To highlight the limited efficacy of current anti-HCV treatments in the post-LTx setting.
  • To discuss strategies for mitigating HBV recurrence and improving survival post-LTx.

Summary:

  • HCV reinfection post-LTx remains a critical clinical challenge with limited effective treatments, impacting long-term survival.
  • For HBV, meticulous patient selection (non-replicative phase), sustained use of hepatitis B immunoglobulin, and novel antiviral drugs have markedly improved graft and patient survival.
  • Effective management of viral hepatitis recurrence is crucial for optimizing outcomes in liver transplant recipients.

Impact:

  • Improved understanding of viral recurrence dynamics post-LTx.
  • Informed clinical decision-making for managing HCV and HBV in transplant patients.
  • Enhanced strategies for improving long-term graft and patient survival after liver transplantation.

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...